Medical device maker Leo Medical Co., Ltd (Leomed) has received over 100 million yuan ($15 million) in a new round of financing, per a company statement on Monday.
CICC Qichen Fund, a sub-fund of CICC Capital, along with healthcare-focused Sunland Fund joined the round.
Leomed will use the proceeds for clinical trials and for marketing expenditure.
Leomed is backed by IDG Capital, LIFE Capital, Frees Fund, and Cowin Capital.
Driven by minimally invasive approaches, Leomed develops medical devices that cater to diagnosis, intervention and treatment of diseases in the digestive and vascular systems.
CHINA DEAL MONITOR
DealStreetAsia has also put together a table listing out all prominent venture capital transactions in the Greater China region on June 25-28, 2021.
